| الإطار الزمني | السعر المتوقع | ماضي | تاريخية | بصيرة |
|---|---|---|---|---|
| غداً | $1.30 ▲ +2.03% | أمس | $1.26 ▼ -0.85% | Tomorrow's TScan Therapeutics Inc. Common Stock (TCRX) setup is anchored to $1.27 and targets $1.30 (+2.03%). The near-term read is upside; watch $1.31 / $1.23 because daily realized volatility is about 8.00%. |
Tomorrow's TScan Therapeutics Inc. Common Stock (TCRX) setup is anchored to $1.27 and targets $1.30 (+2.03%). The near-term read is upside; watch $1.31 / $1.23 because daily realized volatility is about 8.00%. | ||||
| أسبوع | $1.35 ▲ +6.31% | الأسبوع الماضي | $1.24 ▼ -2.65% | The 7-day TScan Therapeutics Inc. Common Stock model moves from $1.24 to $1.35 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.31 / $1.23 matter more than a single tick. |
The 7-day TScan Therapeutics Inc. Common Stock model moves from $1.24 to $1.35 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.31 / $1.23 matter more than a single tick. | ||||
| شهر | $1.44 ▲ +13.45% | الشهر الماضي | $1.20 ▼ -5.65% | The 1-month TScan Therapeutics Inc. Common Stock target is $1.44 (+13.45%), compared with the live reference near $1.27. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month TScan Therapeutics Inc. Common Stock target is $1.44 (+13.45%), compared with the live reference near $1.27. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| سنة | $1.58 ▲ +24.14% | العام الماضي | $1.14 ▼ -10.14% | The 1-year TScan Therapeutics Inc. Common Stock scenario points to $1.58 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year TScan Therapeutics Inc. Common Stock scenario points to $1.58 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 سنوات | $1.89 ▲ +49.20% | منذ 5 سنوات | $1.01 ▼ -20.66% | The 5-year TScan Therapeutics Inc. Common Stock view is $1.89 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year TScan Therapeutics Inc. Common Stock view is $1.89 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| مؤشر | قيمة | إشارة |
|---|---|---|
| Price | $1.27 | Mid |
| Daily Change | -11.19% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 82% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $1.27 | Daily Change | -11.19% |
| Market Cap | $76.33M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.